Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BIOSECURE Act Could Signal a Seismic Shift for Biopharma in US and China
BioSpace
Wednesday, July 31, 2024 - 10:39am
tags:
Biosecure Act, legislaton, China
FDA drug application costs set to rise to $4.3m from October
Clinical Trials Arena
Wednesday, July 31, 2024 - 10:38am
tags:
FDA, regulatory, fees
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wednesday, July 31, 2024 - 10:27am
tags:
inflation, Inflation Reduction Act, drug pricing, Abecma, Breyanzi, Bristol Myers Squibb, Pfizer, Adcetris, Astellas, Padcev, cancer
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wednesday, July 31, 2024 - 10:25am
tags:
Eisai, Biogen, Alzheimer's disease, Leqembi, Europe
Diamyd Medical to continue Phase III trial of type 1 diabetes treatment
Clinical Trials Arena
Wednesday, July 31, 2024 - 10:23am
tags:
Diamyd Medical, clinical trials, Diamyd, type 1 diabetes
FibroGen lays off 75% of US staff as cancer drug flunks 2 more trials
Fierce Biotech
Wednesday, July 31, 2024 - 10:22am
tags:
FibroGen, layoffs, clinical trials, pancreatic cancer
Circular RNA Will Soon Replace mRNA in Biopharma
BioSpace
Wednesday, July 31, 2024 - 10:20am
tags:
circular RNA, MRNA
Vertex gets January 30 decision date for non-opioid pain med suzetrigine
Businesswire
Tuesday, July 30, 2024 - 6:40pm
tags:
Vertex Pharmaceuticals, suzetrigine, non-opioid pain treatments, FDA
Patients push back against Novo Nordisk move to scrap an insulin product
Reuters
Tuesday, July 30, 2024 - 6:37pm
tags:
Novo Nordisk, diabetes, insulin, Levemir, long-acting insulin, patients
Merck mystified by sudden 'step down' in Gardasil sales in China
Fierce Pharma
Tuesday, July 30, 2024 - 6:36pm
tags:
Merck, Gardasil, China
Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents
Fierce Pharma
Tuesday, July 30, 2024 - 6:35pm
tags:
Sarepta Therapeutics, Sanofi, legal, patents, Elevidys, DMD
Merck (MRK) Q2 Earnings and Revenues Top Estimates
Yahoo/Zacks.com
Tuesday, July 30, 2024 - 6:33pm
tags:
Merck, earnings
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
CNBC
Tuesday, July 30, 2024 - 11:55am
tags:
Pfizer, earnings
Pfizer takes $230M hit after axing failed DMD gene therapy—and tosses out RSV combo vaccine
Fierce Biotech
Tuesday, July 30, 2024 - 11:50am
tags:
Pfizer, DMD, gene therapy, RSV
Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial
BioSpace
Tuesday, July 30, 2024 - 11:48am
tags:
Novo Nordisk, liraglutide, clinical trials, Alzheimer's disease
FDA’s Diversity Action Plan may set a new paradigm for trial transparency
Cl
Tuesday, July 30, 2024 - 11:46am
tags:
FDA, regulatory, clinical trials, clinical trial diversity
Incyte drops pair of PD-L1 drugs as part of 2nd pipeline clear-out this year
Fierce Biotech
Tuesday, July 30, 2024 - 11:44am
tags:
Incyte, anti-PD-L1
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tuesday, July 30, 2024 - 11:41am
tags:
BioNTech, Regeneron, Merck, Moderna Therapeutics, mRNA-4157/V940, melanoma
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics: Study
BioSpace
Tuesday, July 30, 2024 - 11:40am
tags:
Novo Nordisk, Ozempic, smoking cessation, GLP-1 agonists
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tuesday, July 30, 2024 - 11:37am
tags:
Eisai, EMA, Europe, Leqembi, Biogen, Alzheimer's disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.